FDA recall, , Moderate risk
American National Red Cross Apheresis Platelets
Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced were exposed to unacceptable storage temperatures.
American National Red Cross (The), Lewis and Clark Region began this recall on Oct 3, 2025. FDA posted it on Nov 4, 2026, the day the recall ended.
Summary by Recall Canary from the FDA notice
What happened
The American National Red Cross, Lewis and Clark Region, based in Murray, Utah, voluntarily recalled Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced after the products were exposed to unacceptable storage temperatures and distributed. The firm initiated the recall on October 3, 2025, and the FDA added it to the Enforcement Report on November 4, 2026. Customers were notified by fax, and the recall applies to Utah.
What to do
Biologics such as blood, tissue and vaccines are usually given by hospitals and clinics. If you had a transfusion, transplant, infusion or vaccine, ask the place that treated you whether this product was used. If they contact you, follow their advice.
What was recalled
Hospitals, clinics and blood banks match these details against their records.
Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced
- Unit number
- W18202583867400X
Recall details
- Posted by FDA
- Recall began
- Status
- Ended Nov 4, 2026
- Weekly archive
- Listed the week of Nov 2, 2026
- Distributed to
- Recalled by
- American National Red Cross (The), Lewis and Clark RegionMurray, Utah
- Hazard
- Processing problem
- Risk
Moderate risk
Its use may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- FDA event number
- 100027
- Recall number
- B-0006-2027
- Recall type
- Voluntary: Firm initiated
- How the company first told customers
- FAX
All recalls from American National Red Cross (The), Lewis and Clark Region
Timeline
FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.
American National Red Cross (The), Lewis and Clark Region began the recall
FDA posted the recall to its Enforcement Report, rated it Class II (moderate risk) and closed it
Added to Recall Canary